Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
2476
DELISTED
Berry Corp
BRY
| $1.11M | ﹤0.01% |
138,500
-55,800
| -29% | -$478K |
|
|
DAO
2477
Youdao
DAO
$2.12B
| $1.1M | ﹤0.01% |
205,450
+175,750
| +592% | +$762K |
|
2478
First Merchants
FRME
$2.69B
| $1.1M | ﹤0.01% |
+26,820
| New | +$1.13M |
|
2479
Paymentus
PAY
$5.05B
| $1.1M | ﹤0.01% |
137,400
+65,894
| +92% | +$646K |
|
|
TDCX
2480
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $1.1M | ﹤0.01% |
88,731
-40,569
| -31% | -$485K |
|
|
LENZ
2481
LENZ Therapeutics
LENZ
$164M
| $1.09M | ﹤0.01% |
47,125
-27,442
| -37% | -$636K |
|
2482
Compass
COMP
$9.4B
| $1.09M | ﹤0.01% |
469,400
-235,700
| -33% | -$618K |
|
2483
Chicago Rivet & Machine Co
CVR
$10M
| $1.09M | ﹤0.01% |
38,210
-3,800
| -9% | -$103K |
|
2484
Walker & Dunlop
WD
$1.52B
| $1.09M | ﹤0.01% |
13,900
-4,400
| -24% | -$370K |
|
|
FSTX
2485
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $1.09M | ﹤0.01% |
171,911
-49,600
| -22% | -$275K |
|
2486
ALX Oncology
ALXO
$284M
| $1.08M | ﹤0.01% |
95,800
-74,800
| -44% | -$840K |
|
2487
Rush Street Interactive
RSI
$2.9B
| $1.08M | ﹤0.01% |
300,800
+277,000
| +1,164% | +$1.03M |
|
2488
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $1.07M | ﹤0.01% |
10,200
+7,300
| +252% | +$766K |
|
2489
Invesco S&P 500 GARP ETF
SPGP
$2.3B
| $1.07M | ﹤0.01% |
13,000
+8,900
| +217% | +$733K |
|
2490
Fidelity Total Bond ETF
FBND
$27.2B
| $1.07M | ﹤0.01% |
+23,810
| New | +$1.07M |
|
2491
iShares Fallen Angels USD Bond ETF
FALN
$1.62B
| $1.07M | ﹤0.01% |
+43,500
| New | +$1.06M |
|
2492
Capital Group Global Growth Equity ETF
CGGO
$11.7B
| $1.07M | ﹤0.01% |
+50,900
| New | +$1.04M |
|
2493
Stoneridge
SRI
$205M
| $1.07M | ﹤0.01% |
49,519
+3,000
| +6% | +$64.2K |
|
|
ARNC
2494
DELISTED
Arconic Corporation
ARNC
| $1.07M | ﹤0.01% |
+50,400
| New | +$1.05M |
|
2495
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.24B
| $1.06M | ﹤0.01% |
+24,257
| New | +$1.06M |
|
2496
Vanguard Russell 1000 Value ETF
VONV
$21B
| $1.06M | ﹤0.01% |
16,000
-500
| -3% | -$32.8K |
|
|
TBI
2497
Trueblue
TBI
$310M
| $1.06M | ﹤0.01% |
54,300
-35,000
| -39% | -$709K |
|
2498
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $1.06M | ﹤0.01% |
25,700
+4,900
| +24% | +$195K |
|
|
FFAI
2499
Faraday Future Intelligent Electric
FFAI
$11.2M
| $1.06M | ﹤0.01% |
3
+1
| +50% | +$668K |
|
2500
Oportun Financial
OPRT
$370M
| $1.06M | ﹤0.01% |
192,500
-53,200
| -22% | -$278K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.